Question 1

Does Rafferty Asset Management own KPTI stock?

Accepted Answer

No. Rafferty Asset Management exited its KPTI (Karyopharm Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 913,301 shares worth $3.6M.

Question 2

How many shares of KPTI does Rafferty Asset Management own?

Accepted Answer

None since Q2 2023, when Rafferty Asset Management exited the position. Its Q1 2023 13F listed 913,301 shares worth $3.6M.

Question 3

What is Rafferty Asset Management's KPTI position worth?

Accepted Answer

Rafferty Asset Management's KPTI position was worth $3.6M in its Q1 2023 13F, before the exit in Q2 2023.

Question 4

Is Rafferty Asset Management buying or selling KPTI?

Accepted Answer

In Q2 2023, Rafferty Asset Management exited its entire KPTI position.

Question 5

When did Rafferty Asset Management first buy KPTI?

Accepted Answer

Rafferty Asset Management first reported KPTI in its Q3 2019 13F and listed it in 15 quarterly 13F filings.